MB

MELISSA BARTLETT

THE ERISA INDUSTRY COMMITTEE · Washington, DC · registered since 2024
Registered · LDAActive

At a glance

Registered since
2024
Senate LDA system
Clients
1
last 3 years
Filings
3
11 agencies contacted
Activity
filings by quarter
Works on

Background

Government experience
Privacy Program Specialist
U.S. Department of Health and Human Services, Office of the Secretary, Office for Civil Rights Counsel, U.S. House of Representatives, Committee on Energy and Commerce
Disclosed on LD-2 filings
Career
Washington, DC
2024 - present

Specific issues

Affordable Care Act, all provisions and related regulations, including reporting (IRC 6055 and 6056), employer mandate, wellness issues, out-of-pocket (OOP) limits, nondiscrimination, PCORI & comparative effectiveness, coverage mandates on ERISA plans, access to preventive care items and services ADA and GINA, HIPAA compliance, privacy, claims data and all payers claims databases mental health, substance use disorders, opioids mitigation tax treatment of employer-sponsored benefits and insurance patent reforms, prescription drug costs, rebates, biosimilars, Rx supply chain, medical management value-driven care in public and private coverage, patient safety Medicare Advantage, Medicare secondary payer, end stage renal disease (ESRD) retiree health, COBRA, Medicare expansion and public option health savings accounts, high deductible health plan expansion ERISA preemption, plan administration, electronic delivery transparency and accountability in the health care system caregiving, surprise medical billing, telehealth expansion, interstate provider licensing hospital billing, consolidation, anti-competitive practices, vertical integration impacts on health care, cybersecurity, artificial intelligence
Health Issues · 2024 Q3
Tax treatment of employer-sponsored health benefits Retirement-related tax issues
Taxation/Internal Revenue Code · 2024 Q3
Affordable Care Act, all provisions and related regulations, including reporting (IRC 6055 and 6056); employer mandate; wellness issues; out-of-pocket (OOP) limits, nondiscrimination, PCORI & comparative effectiveness, coverage mandates on ERISA plans, access to preventive care items and services ADA and GINA, HIPAA compliance, privacy, claims data and all payers claims databases mental health, substance use disorders, opioids mitigation tax treatment of employer-sponsored benefits and insurance patent reforms, prescription drug costs, rebates, biosimilars, Rx supply chain, medical management value-driven care in public and private coverage, patient safety Medicare Advantage, Medicare secondary payer, end stage renal disease (ESRD) retiree health, COBRA, Medicare expansion and public option health savings accounts, high deductible health plan expansion ERISA preemption, plan administration, electronic delivery transparency and accountability in the health care system caregiving, surprise medical billing, telehealth expansion, interstate provider licensing hospital billing, consolidation, anti-competitive practices, vertical integration impacts on health care, cybersecurity, artificial intelligence
Health Issues · 2024 Q2

Clients

2024 · 3 filings
$██,███ / qtrUnlock

Filing history

2024 Q3
ERISA INDUSTRY COMMITTEE
Q3lda.gov →
2024 Q2
ERISA INDUSTRY COMMITTEE
Q2lda.gov →
2024 Q1
ERISA INDUSTRY COMMITTEE
Q1lda.gov →
Showing recent filings · full history on lda.gov